A new strategy for early diagnosis of type 2 diabetes by standard-free, label-free LC-MS/MS quantification of glycated peptides

Diabetes

Volumn 62, Issue 11, 2013, Pages 3936-3942

  Zhang, Mei ^a   Xu, Wei ^a   Deng, Yulin ^a  

^a BEIJING INSTITUTE OF TECHNOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; BIOLOGICAL MARKER; CHOLESTEROL; CREATININE; GLUCOSE; GLYCOSYLATED PROTEIN; HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN; HUMAN SERUM ALBUMIN; LOW DENSITY LIPOPROTEIN; OXYGEN 18; TRIACYLGLYCEROL; URIC ACID; DIAGNOSTIC AGENT; GLYCOSYLATED SERUM ALBUMIN; OXYGEN; PEPTIDE FRAGMENT; SERUM ALBUMIN;

ADULT; AMINO ACID SEQUENCE; ARTICLE; BLOOD SAMPLING; BODY MASS; CONTROLLED STUDY; EARLY DIAGNOSIS; FAMILY HISTORY; FEMALE; GLYCATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LIQUID CHROMATOGRAPHY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MOLECULAR WEIGHT; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROTEIN PROCESSING; PROTEOMICS; QUANTITATIVE ANALYSIS; STANDARD; TANDEM MASS SPECTROMETRY; TIME OF FLIGHT MASS SPECTROMETRY; UREA NITROGEN BLOOD LEVEL; AGED; BLOOD; CHEMISTRY; ELECTROSPRAY MASS SPECTROMETRY; GLUCOSE INTOLERANCE; GLYCOSYLATION; METHODOLOGY; DIABETES MELLITUS, TYPE 2; DIAGNOSTIC USE; PROCEDURES;

ADULT; AGED; AMINO ACID SEQUENCE; BIOLOGICAL MARKERS; CHROMATOGRAPHY, LIQUID; DIABETES MELLITUS, TYPE 2; EARLY DIAGNOSIS; FEMALE; GLUCOSE INTOLERANCE; GLYCOSYLATION; HUMANS; MALE; MIDDLE AGED; OXYGEN ISOTOPES; PEPTIDE FRAGMENTS; SERUM ALBUMIN; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; TANDEM MASS SPECTROMETRY;

EID: 84891691303     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db13-0347     Document Type: Article

References (38)

1. Gardner D, Shoback D. Greenspan's Basic and Clinical Endocrinology. 9th ed. New York, McGraw-Hill Professional, 2011
2. Mason C. The production and effects of uncertainty with special reference to diabetes mellitus. Soc Sci Med 1985;21:1329-1334
3. Clement S, Braithwaite SS, Magee MF, et al.; American Diabetes Association Diabetes in Hospitals Writing Committee. Management of diabetes and hyperglycemia in hospitals. Diabetes Care 2004;27:553- 591
4. Harris MI, Eastman RC. Early detection of undiagnosed diabetes mellitus: a US perspective. Diabetes Metab Res Rev 2000;16:230-236
5. American Diabetes Association. Standards of medical care in diabetes- 2007. Diabetes Care 2007;30(Suppl. 1):S4-S41
6. American Diabetes Association. Screening for type 2 diabetes. Diabetes Care 1998;21(Suppl. 1):S20-S22
7. Klein S, Sheard NF, Pi-Sunyer X, et al.; American Diabetes Association; North American Association for the Study of Obesity; American Society for Clinical Nutrition. Weight management through lifestyle modification for the prevention and management of type 2 diabetes: rationale and strategies: a statement of the American Diabetes Association, the North American Association for the Study of Obesity, and the American Society for Clinical Nutrition. Diabetes Care 2004;27: 2067-2073
8. Beard E, Clark M, Hurel S, Cooke D. Do people with diabetes understand their clinical marker of long-term glycemic control (HbA1c levels) and does this predict diabetes self-care behaviours and HbA1c? Patient Educ Couns 2010;80:227-232
9. Tay TL, Foo JP, Tan E, et al. HbA1c may not be a sensitive determinant of diabetic status in the elderly. Diabetes Res Clin Pract 2011;92:e31- e33
10. Gomez-Marcos MA, Recio-Rodríguez JI, Patino-Alonso MC, et al. Relationships between high-sensitive C-reactive protein and markers of arterial stiffness in hypertensive patients. Differences by sex. BMC Cardiovasc Disord 2012;12:37
11. Tan PC, Aziz AZ, Ismail IS, Omar SZ. Gamma-glutamyltransferase, alanine transaminase and aspartate transaminase levels and the diagnosis of gestational diabetes mellitus. Clin Biochem 2012;45:1192-1196
12. Håglin L, Bäckman L, Törnkvist B. A structural equation model for assessment of links between changes in serum triglycerides, -urate, and -glucose and changes in serum calcium, -magnesium and -phosphate in type 2 diabetes and non-diabetes metabolism. Cardiovasc Diabetol 2011; 10:116
13. Espino A, Villagrán A, Vollrath V, et al. Plasminogen activator inhibitor type 1 serum levels and 4G/5G gene polymorphism in morbidly obese Hispanic patients with non-alcoholic fatty liver disease. Ann Hepatol 2011; 10:493-501
14. Yudkin JS, Stehouwer CD, Emeis JJ, Coppack SW. C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue? Arterioscler Thromb Vasc Biol 1999;19:972-978
15. Rifai N, Tracy RP, Ridker PM. Clinical efficacy of an automated highsensitivity C-reactive protein assay. Clin Chem 1999;45:2136-2141
16. Mendall MA, Strachan DP, Butland BK, et al. C-reactive protein: relation to total mortality, cardiovascular mortality and cardiovascular risk factors in men. Eur Heart J 2000;21:1584-1590
17. Burgert TS, Taksali SE, Dziura J, et al. Alanine aminotransferase levels and fatty liver in childhood obesity: associations with insulin resistance, adiponectin, and visceral fat. J Clin Endocrinol Metab 2006;91:4287- 4294
18. Fraser A, Ebrahim S, Smith GD, Lawlor DA. A comparison of associations of alanine aminotransferase and gamma-glutamyltransferase with fasting glucose, fasting insulin, and glycated hemoglobin in women with and without diabetes. Hepatology 2007;46:158-165
19. Arif B, Ashraf JM, Moinuddin, Ahmad J, Arif Z, Alam K. Structural and immunological characterization of Amadori-rich human serum albumin: role in diabetes mellitus. Arch Biochem Biophys 2012;522:17-25
20. Jones AG, Besser RE, McDonald TJ, et al. Urine C-peptide creatinine ratio is an alternative to stimulated serum C-peptide measurement in late-onset, insulin-treated diabetes. Diabet Med 2011;28:1034-1038
21. Doerr A. Absolute proteomics. Nat Methods 2007;4:195
22. Cheng D, Hoogenraad CC, Rush J, et al. Relative and absolute quantification of postsynaptic density proteome isolated from rat forebrain and cerebellum. Mol Cell Proteomics 2006;5:1158-1170
23. Williams DK Jr, Kovach AL, Muddiman DC, Hanck KW. Utilizing artificial neural networks in MATLAB to achieve parts-per-billion mass measurement accuracy with a fourier transform ion cyclotron resonance mass spectrometer. J Am Soc Mass Spectrom 2009;20:1303-1310
24. Kiernan UA, Addobbati R, Nedelkov D, Nelson RW. Quantitative multiplexed C-reactive protein mass spectrometric immunoassay. J Proteome Res 2006;5:1682-1687
25. Zhang X, Huang B, Zhou X, Chen C. Quantitative proteomic analysis of S-nitrosated proteins in diabetic mouse liver with ICAT switch method. Protein Cell 2010;1:675-687
26. Priego-Capote F, Ramirez-Boo M, Hoogland C, et al. Human hemolysate glycated proteome. Anal Chem 2011;83:5673-5680
27. Metz TO, Qian WJ, Jacobs JM, et al. Application of proteomics in the discovery of candidate protein biomarkers in a diabetes autoantibody standardization program sample subset. J Proteome Res 2008;7:698- 707
28. Zhang Q, Ames JM, Smith RD, Baynes JW, Metz TO. A perspective on the Maillard reaction and the analysis of protein glycation by mass spectrometry: probing the pathogenesis of chronic disease. J Proteome Res 2009;8:754-769
29. Zhang Q, Tang N, Schepmoes AA, Phillips LS, Smith RD, Metz TO. Proteomic profiling of nonenzymatically glycated proteins in human plasma and erythrocyte membranes. J Proteome Res 2008;7:2025-2032
30. Zhang Q, Tang N, Brock JW, et al. Enrichment and analysis of nonenzymatically glycated peptides: boronate affinity chromatography coupled with electron-transfer dissociation mass spectrometry. J Proteome Res 2007;6:2323-2330
31. Zhang Q, Monroe ME, Schepmoes AA, et al. Comprehensive identification of glycated peptides and their glycation motifs in plasma and erythrocytes of control and diabetic subjects. J Proteome Res 2011;10: 3076-3088
32. Ahmad W, Li L, Deng Y. Identification of AGE-precursors and AGE formation in glycation-induced BSA peptides. BMB Rep 2008;41:516- 522
33. Lapolla A, Fedele D, Seraglia R, Traldi P. The role of mass spectrometry in the study of non-enzymatic protein glycation in diabetes: an update. Mass Spectrom Rev 2006;25:775-797
34. Priego-Capote F, Scherl A, Müller M, Waridel P, Lisacek F, Sanchez JC. Glycation isotopic labeling with 13C-reducing sugars for quantitative analysis of glycated proteins in human plasma. Mol Cell Proteomics 2010;9: 579-592
35. Seo J, Lee KJ. Post-translational modifications and their biological functions: proteomic analysis and systematic approaches. J Biochem Mol Biol 2004;37:35-44
36. Barnaby OS, Cerny RL, Clarke W, Hage DS. Quantitative analysis of glycation patterns in human serum albumin using 16O/18O-labeling and MALDI-TOF MS. Clin Chim Acta 2011;412:1606-1615
37. Sattarahmady N, Moosavi-Movahedi AA, Ahmad F, et al. Formation of the molten globule-like state during prolonged glycation of human serum. Biochim Biophys Acta 2007;1770:933-942
38. Wang H, Hu G, Zhang Y, et al. Optimization and quality assessment of the post-digestion 18O labeling based on urea for protein denaturation by HPLC/ESI-TOF mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 2010;878:1946-1952